Talphera, Inc. SEC filings TLPH
Talphera, Inc. has 962 filings in SEC EDGAR's recent list, going back to Feb 19, 2008. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 1, 2026 | — |
| CORRESP | Letter to the SEC | Mar 30, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2026 | — |
| EFFECT | Filing | Dec 1, 2025 | — |
| CORRESP | Letter to the SEC | Nov 25, 2025 | — |
| EFFECT | Filing | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 25, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2025 | — |
| D | Filing | Sep 15, 2025 | — |
| EFFECT | Filing | May 12, 2025 | — |
| CORRESP | Letter to the SEC | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| D | Filing | Apr 17, 2025 | — |
| EFFECT | Filing | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2024 | — |
| D | Filing | Jan 29, 2024 | — |
| EFFECT | Filing | Nov 30, 2023 | — |
| CORRESP | Letter to the SEC | Nov 29, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2023 | — |
| EFFECT | Filing | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Aug 7, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| D | Filing | Jul 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2023 | — |
| CORRESP | Letter to the SEC | Apr 11, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2023 | — |
| EFFECT | Filing | Nov 22, 2022 | — |
| CORRESP | Letter to the SEC | Nov 21, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2022 | — |
| D | Filing | Aug 17, 2022 | — |
| EFFECT | Filing | May 3, 2022 | — |
| D | Filing | Jan 24, 2022 | — |
| EFFECT | Filing | Jul 8, 2020 | — |
| CORRESP | Letter to the SEC | Jul 7, 2020 | — |
| CORRESP | Letter to the SEC | Jul 6, 2020 | — |
| CORRESP | Letter to the SEC | Jul 6, 2020 | — |
| EFFECT | Filing | Jun 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2020 | — |
| 425 | Form 8-k | May 29, 2020 | — |
| 425 | 8-k | May 29, 2020 | — |
| 425 | Form 8-k | May 27, 2020 | — |
| 425 | 8-k | May 27, 2020 | — |
| 425 | Form 425 | May 12, 2020 | — |
| 425 | Form 425 | May 11, 2020 | — |
| 425 | Form 8-k | Apr 30, 2020 | — |
| EFFECT | Filing | Apr 24, 2020 | — |
| CORRESP | Letter to the SEC | Apr 22, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2020 | — |
| 425 | Form 425 | Mar 25, 2020 | — |
| 425 | Form 425 | Mar 17, 2020 | — |
| 425 | Form 425 | Mar 16, 2020 | — |
| 425 | Form 8-k | Mar 16, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2019 | — |
| CORRESP | Letter to the SEC | Nov 7, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2019 | — |
| CT ORDER | Filing | Dec 19, 2017 | — |
| CT ORDER | Filing | Dec 19, 2017 | — |
| CT ORDER | Filing | Nov 30, 2017 | — |
| EFFECT | Filing | Jun 14, 2017 | — |
| CORRESP | Letter to the SEC | Jun 13, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2017 | — |
| CT ORDER | Filing | Mar 17, 2017 | — |
| CT ORDER | Filing | Mar 17, 2017 | — |
| CT ORDER | Filing | Jan 27, 2017 | — |
| CT ORDER | Filing | May 16, 2016 | — |
| CT ORDER | Filing | Dec 8, 2015 | — |
| CT ORDER | Filing | Nov 13, 2015 | — |
| EFFECT | Filing | Jun 12, 2014 | — |
| CORRESP | Letter to the SEC | Jun 11, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2014 | — |
| CT ORDER | Filing | May 16, 2014 | — |
| CT ORDER | Filing | Nov 22, 2013 | — |
| CT ORDER | Filing | May 17, 2013 | — |
| EFFECT | Filing | Dec 6, 2012 | — |
| EFFECT | Filing | Aug 31, 2012 | — |
| EFFECT | Filing | Jul 2, 2012 | — |
| D | Filing | Jun 7, 2012 | — |
| D | Filing | Jul 13, 2011 | — |
| EFFECT | Filing | Feb 10, 2011 | — |
| CORRESP | Letter to the SEC | Feb 4, 2011 | — |
| CORRESP | Letter to the SEC | Feb 4, 2011 | — |
| CERTNAS | Auto-generated paper document | Feb 2, 2011 | — |
| 8-A12B | Form 8-a12b | Feb 1, 2011 | — |
| CORRESP | Letter to the SEC | Feb 1, 2011 | — |
| CORRESP | Letter to the SEC | Feb 1, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2010 | — |
| D | Filing | Sep 21, 2010 | — |
| D | Filing | Nov 25, 2009 | — |
| REGDEX | Auto-generated paper document | Feb 19, 2008 | — |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Mateo, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1427925
- Former names
- ACELRX PHARMACEUTICALS INC (until Dec 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.